Activation of extracellular-signal-regulated protein kinase (Erk) is central to growth-factor-receptor-mediated signaling including that originating from the T cell antigen receptor. It integrates cytoplasmic signals to effect changes in transcription associated with differentiation, proliferation, and survival. In this report, we present an analysis of mice with targeted deletions in Erk1 and Erk2 to assess the relationship between Erk activity and cell-cycle progression, thymocyte development, and lineage commitment. These studies show that Erk is selectively retained during ␤ selectiondriven proliferation, and yet Erk1/2 are not required to complete differentiation to CD4 + CD8 + preselection stage of development. Erk activity is essential for the process of positive selection, and it differentially affects CD4 and CD8 T cell maturation; yet, diminished expression itself is not sufficient to alter lineage commitment.
Introduction

T cell development proceeds in an ordered
To overcome early lethality, we generated mice in which the Erk2 gene was conditionally deleted at two different stages in thymic development. The analyses of these mice reveal that the MAP kinase pathway differentially affects at least two stages in thymic development.
Results
Mice with a Hemizygous Erk2 Deficiency Exhibit Embryonic Lethality
Germline deletion of Erk2 was accomplished with a targeting vector as depicted in Figure S1 in the Supplemental Data available with this article online. From 60 Erk2 +/− × Erk2 +/− offspring, no homozygous mice were born. In addition, Erk2 +/− mice were backcrossed to C57BL/6 in two separate experiments, and the number of heterozygous Erk2 +/− progeny was tallied. As shown in Figure S2 , the number of progeny with a hemizygous Erk2 deficiency decreased such that at generation four, only one Erk2 +/− mouse was recovered. When a generation-three mouse was crossed to strain SVJ/129, the Erk2-deficient allele transmitted at a frequency of 50%. There would seem to be a strict requirement for the full level of Erk2 expression during development that can be dominantly suppressed by one or more genes present in the SVJ/129 strain. We did not determine the stage at which development was aborted in the hemizygous Erk2-deficient embryos, although we note that three other Erk2 mutant strains exhibited homozygous lethality at three different embryonic stages (Saba-ElLeil et al. To avoid embryonic lethality, we modified the Erk2 locus by homologous recombination for conditional deletion ( Figure 1A ). Female mice containing the targeted allele (Erk2 fn ) were bred with EIIa-cre transgenic mice, and the progeny were screened for a recombination event that retained exon 3 but deleted PGK-neo (Erk2 f ) (Lakso et al., 1996; Holzenberger et al., 2000) . Mouse strains with either the Erk2 f or Erk2 fn alleles were used to assess the requirement for Erk2 in T cell development.
Deletion of Erk2 in DN3 Thymocytes
Decreases Thymic Cellularity Germline transmission of each allele was tested by Southern blotting and PCR. Homozygous Erk2 f/f and Erk2 fn/fn mice were found to express the same levels of Erk2 protein and have normal T cell development indicating that the modification of the Erk2 locus with or without PGK-neo did not disrupt gene regulation (Figure 1B) . Both alleles were crossed with pLck-cre transgenic mice in order to express the cre recombinase in the T cell lineage prior to the β selection checkpoint (Lee et al., 2001; Wolfer et al., 2002) . The two alleles were comparably expressed and deleted with no detectable differences ( Figure 1B) . In order to determine the stage of Erk2 deletion, we sorted DN3 and DN4 populations and tested them for exon 3 deletion and Erk2-protein loss ( Figure 1C) In mice deleted for Erk2, the numbers of total and DP thymocytes were reduced by about 30%, consistent with a partial block in the expansion associated with the DN-to-DP transition or a reduction in cell survival ( Figure 1D ). In order to examine this directly, we analyzed the DN subpopulations, as measured by the expression of CD25 and CD44, were analyzed ( Figure 1E ). Indeed, there was a substantial increase in the number of DN3 thymocytes, consistent with a partial block in the DN3 to DN4 maturation step.
Deletion of Both Erk1 and Erk2 Does Not Prevent Maturation to the DP Stage of Development
To determine the roles of Erk1/2 in the DN-to-DP transition, we crossed Erk2 fn/fn ;pLck-cre mice to mice with a germline deficiency in Erk1 (Pages et al., 1999). As described above, thymocytes from Erk2 f/f ;pLck-cre mice showed a partial block at the DN3 stage ( Figures  1E and 2A) , although cells progressed to the DN4 stage and beyond. Densitometry of Erk2 protein ( Figure 1C ) revealed that its expression was decreased approximately 3-fold at the DN3 stage and from 25-100-fold at the DN4 stage. More importantly, in Erk1 −/− ;Erk2 f/f ;Lckcre mice, the thymocytes progressed to the DN4 stage and, as we will show below, were competent to progress to the DP stage of development with no detectable Erk1/2 protein remaining.
To investigate this partial block, we looked at two major characteristics of DN-thymocyte developmentproliferation and TCR β chain expression. The rate of thymocyte proliferation in vivo was assessed by injecting bromodeoxyuridine (BrdU) and harvesting the thymocytes 3 hr later. The result was that thymocytes from Erk2 fn/fn ;pLck-cre mice exhibited normal or even slightly enhanced BrdU uptake in the DN4 population ( Figure 2B) . Surprisingly, this was true for thymocytes from Erk1 −/− ;Erk2 fn/fn ;pLck-cre mice as well. In addition, we found a high degree of variability in the mice deficient for both Erk isoforms. Whereas some mice had very small thymuses (13 × 10 6 cells) and few DN4 cells, others had larger thymuses (115 × 10 6 cells) with only a moderate block at the DN3 stage of development ( Figure 2C ). To determine the effectiveness of Erk2 deletion in the absence of Erk1, we isolated the DN3 and DN4 populations by cell sorting and analyzed them for Erk2 by western blotting. The results showed that, in the absence of Erk1, Erk2 protein was unchanged at the DN3 stage and was reduced but still detectable at the DN4 .
A second parameter we tested was the expression of the TCR β chain. Erk-deficient DN3 cells expressed normal levels of intracellular β chain, indicating that rearrangement and protein production were intact ( Figure  2E ). At the DN4 stage, there was an increased population of cells from Erk2-deficient and Erk-deficient mice that expressed no intracellular β chain. This result was found consistently for Erk2-deficient DN4 thymocytes defined as B220 These experiments reveal that that Erk is required for proliferation and differentiation associated with β selection, such that in the absence of Erk1, there is a selection for the retention of a small amount of Erk2. We infer that under physiological conditions, Erk expression is in excess over that which is required for continued proliferation. As an aside, we note that the pLck-cre transgene itself affects T cell development to an extent (Mertsching et al., 2002) , and it is thus essential in carrying out experiments of this type to compare cre transgenic mice with and without loxP-flanked alleles.
The Expression of Erk1/2 Is Essential for Positive Selection
Thymocyte populations were measured by the expression of the CD4 and CD8 coreceptors, TCR β chain, and CD69. As expected, the thymocyte subsets from 
Erk2
f/f , Erk2 fn/fn , and wild-type mice were not significantly different (Figure 3A) , although the introduction of pLck-cre transgene appears to have caused a small decrease in mature thymocytes. The phenotype of Erk1 +/+ ;Erk2 f/+ ;pLck-cre mice was also similar to pLckcre mice, and this is consistent with our analysis of thy- mocytes from Erk2 +/− mice ( Figure 3A and data not shown). In this analysis, we also did not find a difference in the thymus subsets from mice that were deficient only for Erk1. We surmise that the difference between this and the previous report may be ascribed to genetic variations caused by backcrossing to C57BL/6 mice (Pages et al., 1999). In contrast, loss of both Erk isoforms in Erk1 −/− ;Erk2 fn/fn ;pLck-cre mice was permissive for the appearance of a substantial DP population, but it was not permissive for the positive-selectionassociated appearance of mature CD4 or CD8 T cells.
Because the levels of TCR β chain and CD69 increase with positive selection, we used a bivariant plot of these two cell-surface molecules to reveal the percentage of cells undergoing positive selection. As shown, a small number of thymocytes undergo positive selection in the presence of Erk1, whereas virtually no mature cells were detected in the absence of both isoforms ( Figure 3B ). These results show that the development of a small number of single positive thymocytes in Erk2 f/f ;pLck-cre mice was dependent on the activity of Erk1, and this verifies previous results showing that Erk1 plays a role in positive selection (Pages et al., 1999). We can conclude that quantitatively, Erk2 is substantially more important than Erk1, although we cannot say whether this is due to abundance or activity.
Because Erk1 and Erk2 are both expressed in thymocytes and appear to be at least partially redundant, a deficiency in Erk2 alone constitutes the equivalent of a hypomorphic mutation in this essential signaling pathway. With this in mind, we plotted the number of CD4 and CD8 thymocytes found in Erk2-deficient mice and their wild-type littermates. As depicted in Figure 3C , although there is a decrease in both the CD4 and CD8 subsets, CD4 thymocytes are preferentially affected such that the CD4:CD8 ratio goes from 3.2 in wild-type mice to 2.2 in Erk2-deficient mice. An implication of this result is, minimally, that CD4 T cell differentiation exhibits a greater dependence on Erk signaling compared with CD8 differentiation.
fn/fn ;Cd4-cre Mice Have Defects in Positive Selection Because Erk2 f/f ;pLck-cre mice demonstrated a partial block in DN3 to DN4 progression, we were concerned that this might carry over to later stages of development. Therefore, to address the role of Erk2 in DP thymocytes, we bred mice with the Erk2 fn allele to coex- press the later-deleting Cd4-cre transgene. Figure 4A depicts the thymocyte subset analysis from a representative set of mice with different Erk genotypes. Once again, mice with a hemizygous Erk2 deficiency were within the range expected for wild-type mice, whereas Erk2 fn/fn ;Cd4-cre mice exhibited a decrease in the number of CD4 and CD8 SPs. This phenotype was accentuated by a deficiency in Erk1. Thymocytes that had recently undergone positive selection were again enumerated by measuring the relative expression levels of CD69 and the TCR β chain. By this measure, there was a significant reduction in the percentage of positively selected thymocytes in both Erk2 fn/fn ;Cd4-cre and Erk1 −/− ;Erk2 fn/fn ;Cd4-cre mice. In comparison to deletion with the pLck-cre transgene, overall thymic cellularity was restored in Erk2 fn/fn ;Cd4-cre mice with an increase in the proportion of DP thymocytes and a compensatory decrease in single positive thymocytes ( Figure 4C) . In contrast to Erk1/2-deficient mice generated with the pLck-cre transgene, Erk1 −/− ;Erk2 fn/fn ;Cd4-cre mice retained significant populations of SP thymocytes.
In order to determine the efficiency of deletion with the Cd4-cre transgene, we sorted DP and CD4 thymocytes and tested them for Erk2 protein and the Erk2 exon 3 deletion. Although DP thymocytes had completely deleted exon 3 of Erk2 as measured by PCR, residual Erk2 protein was easily detectable. The turnover of Erk2 is such that it did not persist in CD4SP thymocytes ( Figure 4B ). Again, a decrease in the amount of Erk expressed was correlated with a decrease in the CD4-to-CD8 ratio of mature TCR hi thymocytes ( Figure 4C) . We conclude that the few mature thymocytes produced in Erk1 −/− ;Erk2 fn/fn ;Cd4-cre mice most likely achieved maturity as a result of enduring Erk2 protein in the DPs. The presence of an Erk1 deficiency did not result in an alternation in the thymocyte subsets, and this is consistent with our analysis of T cell development in Erk1-deficient mice without a TCR transgene. Although there are apparent subtle differences in the examples presented in Figure 5 , these differences were within the range of values characteristically found for AND mice ( Figure 5A and 5B). In contrast, AND;Erk2 fn/fn ;Cd4-cre mice exhibited an altered proportion of DP and CD4 populations ( Figure 5A ). This was accompanied by a reduction in the percentage of TCRhi, CD69hi, and CD69lo thymocytes in AND;Erk2 fn/fn ;Cd4cre mice, suggesting inefficient positive selection. Positive selection was diminished further in AND;Erk1 +/+ ;Erk2 fn/fn ;pLckcre mice and in AND;Erk1 −/− ;Erk2 fn/fn ;Cd4-cre mice, reflecting the reduced levels of total Erk molecules in these two genotypes.
Erk Deficiency Preferentially
To reveal the percentage of cells that have completed positive selection, we gated the CD69 lo Vα11 hi cells for CD4 and CD8 ( Figure 5C ). This analysis revealed that the number of CD4 cells diminished with levels of expressed Erk, and these cells were not replaced by mature CD8 thymocytes. As such, a simple decrease in Erk activity is not sufficient to cause MHC-class-II-specific thymocytes to differentiate into the CD8 lineage. We did notice that the ratio of CD4 to CD8 T cells changed dramatically. Whereas AND mice exhibited a CD4-to-CD8 ratio of 257 in this example, AND;Erk2 fn/fn ;pLckcre mice exhibited a CD4-to-CD8 ratio of 20 ( Figure 5C , insert box). This was a consistent trend in dozens of mice of different genotypes, and we interpret it to mean that CD8 development has less of a requirement for Erk-dependent signal transduction. Because the cells were gated for a Vα11 hi phenotype, we consider the possibility that these cells express a second TCR α chain to be unlikely. The total number of thymocytes was also found to reflect the amount of Erk (Figure 5D ), even though the Cd4-cre transgene becomes transcriptionally active subsequent to the expansion associated with β selection. Because there is minimal proliferation in the later stages of thymic development, this decrease in cell number could reflect diminished cell survival or accelerated migration into the peripheral lymphoid organs.
A different result was obtained in the analysis of OT-I mice. The development of CD8 thymocytes was not as sensitive to the deletion of the Erk2 gene (Figures 6A-6C) . Previous work has shown that at least a subset of CD4 + CD8 lo thymocytes have received a posi- 
tive-selection signal and may or may not be committed to one of the two T cell lineages (Lucas and Germain, 1996; Suzuki et al., 1997). Consistent with this idea, in thymuses from OT-I mice decreases in Erk correlated with decreases in the percentage of CD4
+ CD8 lo thymocytes, and this decrease was not entirely compensated by the increase in thymocyte cell number (Figures 6A  and 6D ). Yet, the maturation of CD8 OT-I thymocytes was only minimally affected. This can be readily seen by the ratio of CD4 + CD8 lo to CD4 − CD8 + thymocytes ( Figure 6A ).
In the analysis of OT-I thymocytes, we found that a bivariant plot of TCR (Vα2) versus CD69 did not yield clearly definable subsets, so we instead enumerated the mature thymocytes on the basis of a Vα2 hi HSA lo phenotype ( Figure 6B ). Again, we found that the ratio of CD4 to CD8 mature thymocytes decreased with a decreased expression of Erk ( Figure 6C , insert box) with one exception. In the Erk1/2-deficient mice, the ratio increased back to wild-type levels. We explain this by noting that DPs in these mice have lower levels of Vα2 and thus probably express endogenous TCR α chains. We conclude that a partial loss of Erk2 in OT-I mice had a marked effect on the efficiency of positive selection with less of an effect on the net steady-state number of mature CD8 thymocytes. We have no simple explanation for the reduced-Erk-associated increase in total thymocytes ( Figure 6D ), although perhaps Erk signaling can play a role in cell death-either negative selection caused by a superoptimal selection signal or death by neglect. Another possibility is that Erk does not mediate cell death, but with decreased Erk, fewer thymocytes have been diverted into a nonproductive CD4 pathway. 
Erk1 and Erk2 Both Regulate Egr1 Expression To investigate the contributions of Erk isoforms to the regulation of downstream target genes, we examined Egr1 induction in DPs with or without the expression of
Discussion
In this report, we describe a newly derived strain of mice in which the Erk2 gene can be inactivated by the tissue-specific expression of the cre recombinase. In conjunction with a germline mutant allele of Erk1, we were able to dissect the role of these two canonical In keeping with these results, previous experiments, including our own, showed that proliferation and differentiation associated with the β selection checkpoint are highly dependent on Mek (Crompton et al., 1996; Sharp  et al., 1997) . To address this issue more conclusively, we analyzed early thymic development in mice deficient for Erk1/2; however, because Erk2 was conditionally deleted, there exists the potential for retention of Erk2 protein during differentiation. By comparing the signal in the DN4 subset from Erk1/2 knockout mice with a titration of cell equivalents from wild-type mice, we found that the decrease in Erk2 is less than 2-fold. Presumably, only those DN4 cells with Erk2 continue to divide, although the same is not true for the DP population. The abundance of DPs allowed us to analyze ten times as many cells, and yet we found no detectable Erk-protein expression (Figure 7) . We interpret these data to show that Erk is necessary for proliferation associated with β selection, but not to complete the DN4 to DP differentiation step.
To account for the variability in the expansion of DN3 thymocytes and the retention of Erk2 protein at the DN4 stage, we propose that continued Erk signaling is required through at least the DN4 stage of development. We speculate that the variability reflects the timing of Erk2 deletion with respect to a productive TCR β chain rearrangement. Those cells that complete a productive rearrangement while retaining a sufficient level of Erk2 are able to sustain proliferation. Such a geometric expansion, sensitive to initial conditions, is likely to exhibit a variable outcome.
The second checkpoint in thymocyte development is positive selection and the associated fate specification resulting in regulated differentiation of CD4 and CD8 T cells. In many unbiased genetic screens for genes involved in fate specification associated with organogenesis, the MAP kinase pathway has been shown to play an essential role. Cells receiving a strong signal originating from a receptor tyrosine kinase adopt a primary cell fate, whereas cells receiving a weaker signal can adopt a secondary fate depending on other signals received ( . We emphasize that all genetic or pharmacological manipulations result in pleiotropic effects, and so understanding comes from multiple independent approaches to a problem.
Consistent with a role for Erk beyond positive selection, we found that CD4 and CD8 thymocyte differentiation exhibited a differential requirement for Erk. The ratio of CD4 to CD8 SP thymocytes decreased with decreasing amounts of Erk whether Erk2 was deleted early with Lck-cre or later with Cd4-cre. These results were reinforced by experiments with TCR transgenic mice. Decreasing amounts of Erk had a proportionate effect on the number of CD4 SP thymocytes in AND mice, whereas equivalent losses of Erk had little affect on the number of CD8 SPs in OT-I mice. Whether or not the analyses were carried out with TCR transgenic mice, the ratio of CD4 to CD8 SP thymocytes was decreased in proportion to the level of Erk expression.
The major question is whether the level of Erk (and presumably Erk activity) is deterministic for CD4 and CD8 lineage commitment analogous to its role in the models cited above. In the present analysis, we found that a progressive loss of signaling through the MAP kinase pathway was not sufficient, in itself, to cause MHC-class-II-specific thymocytes to assume a CD8 phenotype. This is in contradistinction to studies also using AND TCR transgenic mice in which CD4 was deleted (Matechak et al., 1996) , ZAP70 activity was temporally attenuated (Liu and Bosselut, 2004), or Lck activity was diminished with a distal Lck-driven kinasedead form of Lck (Hernandez-Hoyos et al., 2000) . The latter study is most analogous to the work presented here, and yet we note that an earlier analysis with the same dominant-negative Lck transgene did not observe a change in lineage commitment (Hashimoto et al., 1996) . In addition, diminished TCR signaling achieved via mutations in the TCR zeta chain also did not cause a shift to the CD8 lineage in AND mice (Shores et al., 1997) .
One possibility is that the strength of signal affects the probability that DPs will undergo positive selection with a bias, reinforced by selection, toward a given fate ( 
Experimental Procedures Mice
Mice harboring the erk2 exon 3 conditional allele were generated by the UCSD Transgenic Mouse Core Facility as described in Supplemental Experimental Procedures. The Erk2 fn allele was typed with the primers, 5#-GAACTTACTATGCACATCAGG-3# (p2 in Figure  1 ) and 5#-ACACAGTATGAGTCTCATTCC-3# (p3 in Figure 1 ). The Erk2 f allele was typed with the primers, 5#-TAGCAG GTGGATATC TAAGC-3# (p1 in Figure 1 ) and 5#-GGTAACAAGAGCAACACGTGC-3# (p4- Figure 1 ). Cd4-cre and Lck-cre mice were obtained from Taconic Labs. OT-I mice were a gift from Kristen Hogquist. AND mice were bred in our facility and backcrossed to C57BL/6 for nine generations. All mice were housed at UCSD under institutional guidelines.
FACS Analysis
For total thymocyte analysis, cells were stained with anti-CD69FITC, anti-TCRβPE (H57), anti-CD8PerCP and anti-CD4APC. For analysis of DN-thymocyte populations, cells were stained with a biotin cocktail containing antibodies against CD4, CD8, γδTCR, B220, and MHC class II and then stained with strepavidinPerCP, CD25FITC, and CD44APC. For intracellular β chain staining via H57PE, cells were fixed with Cytofix and permeablized by Cytoperm (BD Pharmingen) as per instructions by the manufacturer. All fluorescent antibodies used in this study were purchased from eBioscience except for PerCP antibodies that were purchased from BD Pharmingen.
BrdU Analysis
Mice were innoculated with 100 l of a 10 mg/ml BrdU stock intraperitoneally 3 hr before the thymus was harvested. Thymocytes were stained with the same biotin antibody cocktail as stated above and then stained with strepavidin-PerCP, CD25PE, and CD44APC. Cells were placed in BrdU buffer overnight (PBS, 0.01% tween20, 1% paraformaldehyde). One milliliter of fresh 0.1 mg/ml DNase was added and then incubated for 1 hr at 37°C. Cells were stained with 10 l/10 6 cells of anti-BrdU FITC (BD Pharmingen) for 30 min at room temperature.
Western Analysis
× 10
6 thymocytes were lysed with high-salt lysis buffer (20 mM Hepes [pH 7.9], 420 mM NaCl, 0.1 mM EDTA, 1.5 mM MgCl 2 , 25% glycerol) with protease and phosphatase inhibitors (Cell Signaling). Supernatants were separated by 10% polyacrylamide SDS gel electrophoresis (BioRad) and transferred to a PVDF membrane (Millipore). Blots were incubated with primary antibody at 4°C overnight and secondary HRP antibody (Vector Labs) for 2 hr. ECL (Amersham) chemistry was used to visualize protein products. Anti-Erk antibodies were from Santa Cruz Biotech (C-14) and Zymed. The anti-Egr1 antibody was obtained from Active Motif, and the ZAP-70 mouse monoclonal antibody was obtained from Transduction Laboratories.
Isolation of Thymocyte Subsets DN3, DN4, DP, and CD4 thymocytes were sorted by The Scripps Research Institute cell-sorting facility. Western blots were performed with extracts from 10 5 thymocytes, and PCR was performed with 10 4 cells. Deletion of Erk2 exon 3 was analyzed with p2 and p3 to detect loxP sequence and with p1 and p3 to detect to loss of exon 3 (above).
Thymocyte Stimulations
Purification of preselecting DP thymocytes were done by first collecting the CD3 − fraction off of a MACS column (Miltenyi Biotech) and then by collecting the CD8 + fraction. Two milliliters of 2.5 × 10 6 cells/ml of purified preselecting DP thymocytes were plated into a 35 mm dish. Samples were stimulated with 5 l of a 4 g/ml PMA stock (CalBiochem) for 45 min. Stimulated and unstimulated samples were washed with 13 ml cold PBS and lysed as described above. 
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